A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine

NCT02585700 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Virology, Vaccines and Sera, Torlak

Collaborators